Company: HMDCF
Filing Date: 2025-03-19
Form Type: 20-F
Source: 0001410578-25-000377
Chunk: 683

Company: HUTCHMED (China) Ltd
Filing Date: 2025-03-19
Form: 20-F
Item: Item 16K
Chunk 683
---
 investee (note (e)) 142 450
An indirect subsidiary of CK Hutchison (note (f)) 6,475 7,619
6,617 8,069
Notes:
(a) On December 7, 2023, the Group completed a transaction to divest Hutchison Hain Organic (Hong Kong) Limited and HUTCHMED Science Nutrition Limited to an indirect subsidiary of CK Hutchison for...

F-44

Table of Contents

  (b)      Balances with related parties are unsecured, repayable on demand and interest-free. The carrying values of balances with related parties approximate their fair values due to their short-term ma...  
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  (c)      As at December 31, 2024 and 2023, dividends receivable of US $ 6,795,000 and US $ 27,130,000 was included in amounts due from related parties respectively.  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  (d)      Amounts due to indirect subsidiaries of CK Hutchison are unsecured, repayable on demand and interest-bearing if not settled within one month.  
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  (e)      Includes other deferred income representing amounts recognized from granting of commercial, promotion and marketing rights.  

  (f)      As at December 31, 2024 and 2023, a branding liability payable of US $ 1,538,000 was included in amounts due to related parties under other payables, accruals and advance receipts. As at Decemb...  
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  (iii)      Transactions with non-controlling shareholders of subsidiaries:  
 ──────────────────────────────────────────────────────────────────────────────

                                Year Ended December 31,                          
                                                   2024        2023        2022  
 ─────────────────────────────────────────────────────────────────────────────────
                                         (in US$ ’ 000)                          
  Sales                                          54,532      66,417      47,611  
  Purchases                                         288